---
annotations:
- type: Pathway Ontology
  value: unsaturated fatty acid biosynthetic pathway
authors:
- ReactomeTeam
- DeSl
- Marvin M2
description: Docosahexaenoic acid (DHA), a major Ï‰-3 polyunsaturated fatty acid (PUFA)
  found in fish oil is the source of D-series resolvins (RvDs), one of the specialized
  proresolving mediators (SPMs) that show potent anti-inflammatory and pro-resolving
  actions (Molfino et al. 2017). The biosynthesis of RvDs occurs mainly during the
  process of inflammation when endothelial cells interact with leukocytes. Dietary
  DHA circulates in plasma or is present in cellular membranes as it can easily integrate
  into membranes. On injury or infection, DHA moves with edema into the tissue sites
  of acute inflammation where it is converted to exudate RvDs to interact with local
  immune cells (Kasuga et al. 2008). The initial transformation of DHA by aspirin-acetylated
  cyclooxygenase-2 or cyclooxygenase-mediated catalysis can produce stereospecific
  D-resolvins (18(R)- or 18(S)-RvDs respectively). Combinations of oxidation, reduction
  and hydrolysis reactions determine the type of D-resolvin formed (RvD1-6) (Serhan
  et al. 2002, Serhan & Petasis 2011, Serhan et al. 2014).   View original pathway
  at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=9018677 Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP4439
- /instance/WP4439
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP4439.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Docosahexaenoic acid (DHA), a major Ï‰-3 polyunsaturated fatty acid
    (PUFA) found in fish oil is the source of D-series resolvins (RvDs), one of the
    specialized proresolving mediators (SPMs) that show potent anti-inflammatory and
    pro-resolving actions (Molfino et al. 2017). The biosynthesis of RvDs occurs mainly
    during the process of inflammation when endothelial cells interact with leukocytes.
    Dietary DHA circulates in plasma or is present in cellular membranes as it can
    easily integrate into membranes. On injury or infection, DHA moves with edema
    into the tissue sites of acute inflammation where it is converted to exudate RvDs
    to interact with local immune cells (Kasuga et al. 2008). The initial transformation
    of DHA by aspirin-acetylated cyclooxygenase-2 or cyclooxygenase-mediated catalysis
    can produce stereospecific D-resolvins (18(R)- or 18(S)-RvDs respectively). Combinations
    of oxidation, reduction and hydrolysis reactions determine the type of D-resolvin
    formed (RvD1-6) (Serhan et al. 2002, Serhan & Petasis 2011, Serhan et al. 2014).   View
    original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=9018677 Reactome].
  keywords:
  - '7-epi-MaR1 '
  - 17(R)-HDHA
  - '14(S),21(S)-diHDHA '
  - RvD3, RvD4
  - Maresins
  - AT-RvD1, AT-RvD2
  - 'O-acetyl-L-serine-PTGS2 '
  - 'CYP2D6 '
  - AT-RvD5
  - MaR1
  - LTC4S trimer
  - MaR-L1
  - DPEP
  - 17R(16)-epoxy-DHA
  - 'resolvin D4 '
  - GSH
  - 'AT-RvD6 '
  - NADPH
  - 'CYP2C9 '
  - 4S(5)-epoxy-17(S)-HDHA
  - 'LTA4H '
  - GSSG
  - GGT
  - PDX
  - H+
  - 17(S)-Hp-DHA
  - 14(S),21(S/R)-diHDHA
  - Protectins
  - AT-RvD3, AT-RvD4
  - 'RCTR3 '
  - 'Mg2+ '
  - H2O
  - 'AT-RvD5 '
  - RCTR3
  - '8-oxo-17(S)-RvD1 '
  - oxidised acceptor
  - 14(S)-Hp-DHA
  - 13(S),14(S)-epoxy-DHA
  - sulfido conjugates
  - 22-OH-(N)PD1
  - 'MCTR3 '
  - 'MaR-L2 '
  - 17(R)-Hp-DHA
  - Gly
  - MaR-L2
  - 17(S)-HDHA
  - NADP+
  - resolvin D5
  - 'Zn2+ '
  - 'resolvin D3 '
  - 'PCTR2 '
  - MaR2
  - CYP2E1
  - PCTR1
  - 'MCTR2 '
  - 'PCTR1 '
  - 7(S)-Hp-17(S)-HDHA
  - AT-RvD6
  - 'aspirin-triggered resolvin D5 '
  - 'RCTR1 '
  - 7(S),17(S)-diHp-DHA
  - 'aspirin-triggered resolvin D6 '
  - 'PTGS2 '
  - 'CYP3A4 '
  - '14(R),21(S)-diHDHA '
  - Ac-PTGS2 dimer
  - 'aspirin-triggered resolvin D3 '
  - 'heme b '
  - 14(S)-HDHA
  - CYP4
  - PCTR3
  - HPGD dimer
  - 4(S)-Hp-17(S)-HDHA
  - 'CYP2C8 '
  - 'EPHX2 '
  - '(N)PD1 '
  - 'Fe2+ '
  - 'resolvin D5 '
  - 'MCTR1 '
  - ALOX5
  - Lipoxygenase
  - AT-RvD1-6
  - MCTR3
  - RvD1
  - 14(R)-HDHA
  - 'PDX '
  - 16S,17S-epoxy-DHA
  - 'ALOX12 '
  - RvD1-6
  - PCTR2
  - '17(S)-oxo-RvD1 '
  - 7-epi-MaR1
  - '14(R),21(R)-diHDHA '
  - CYP1A1, CYP1A2
  - AT-(N)PD1
  - 7(S)-Hp-17(R)-HDHA
  - GSTM4 dimer
  - NAD+
  - 14(R),21(S/R)-diHDHA
  - 'MaR1 '
  - LTA4H:Zn2+
  - '14(R),21(S/R)-diHDHA '
  - O2
  - MCTR2
  - 7S(8)-epoxy-17(S)-HDHA
  - L-Glu
  - 7S(8)-epoxy-17(R)-HDHA
  - RCTR1
  - reduced acceptor
  - resolvin D6
  - MCTR1
  - 'CYP1A1 '
  - DHA
  - '22-OH-(N)PD1 '
  - 'CYP1A2 '
  - 'RCTR2 '
  - reductase
  - 'MaR2 '
  - 'resolvin D6 '
  - 'AT-(N)PD1 '
  - 'aspirin-triggered resolvin D4 '
  - 8-oxo-17(S)-RvD1
  - Hydroperoxy
  - Maresin-like SPMs
  - 7(S),14(S)-diHp-DHA
  - 4S(5)-epoxy-17(R)-HDHA
  - 'aspirin-triggered resolvin D2 '
  - EPHX2 dimer
  - RCTR2
  - 4(S)-Hp-17(R)-HDHA
  - CYP1A2,2C8,2C9,2D6,2E1,3A4
  - 'CYP2E1 '
  - 'PCTR3 '
  - (N)PD1
  - ALOX15
  - NADH
  - Epoxide hydrolase
  - '14(S),21(S/R)-diHDHA '
  - 'RvD1 '
  - ALOX12:Fe2+
  - 'AT-RvD1 '
  - 17(S)-oxo-RvD1,
  - GPX4-2
  - 'HPGD '
  - 'MaR-L1 '
  - 'LTC4S '
  - '14(S),21(R)-diHDHA '
  - 'RvD2 '
  - RvD1, RvD2
  - 'GSTM4 '
  license: CC0
  name: Biosynthesis of DHA-derived SPMs
seo: CreativeWork
title: Biosynthesis of DHA-derived SPMs
wpid: WP4439
---